2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summit

We are pleased to invite you to the 2nd Annual Microbiome: Translating into Diagnostics and Therapeutics Summit scheduled for October 2nd - 3rd, 2018 in Vienna, Austria.

This premier B2B event provides you with an appropriate platform to engage with and discuss ideas with your fellow peers while facilitating a professional atmosphere and environment for excellent company representation and development.

The Summit will shed light on current challenges, best practices, and inside views of the future of Microbiome in relation to precision medicine.

We will discuss key findings, critical insights, and recommendations for driving efficient strategies within the Microbiome landscape.

It is an honour and privilege to invite you to participate in this Summit. We look forward to welcoming you in Vienna in October!

Key Practical Learning Points of the Summit:

  • Emerging science and technologies for successful Microbiome discovery and translation
  • Translation of Microbiome products:
    • Into clinical trials
    • For healthy nutrition
    • Into personalized therapeutics and diagnostics
  • Clinical applications of Microbiome in oncology & beyond
  • Regulatory compliance for Microbiome drugs
  • Commercialization and investment perspectives of Microbiome – based diagnostics and therapeutics

Who Should Attend:

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders, and Managers specialising in:

  • Microbiome/Microbiota
  • Bacteria / Fungi / Viruses
  • Microbiology
  • Molecular Biology
  • Computational biology
  • Molecular Diagnostics
  • Autoimmune Disease
  • Immuno-oncology
  • Infectious Diseases
  • Metabolic Disease
  • Inflammation
  • Vaccines
  • Food/Nutrition Science
  • Neurodegeneration / Gut-Brain Axis
  • Genotyping
  • Genomics
  • Biomarkers
  • Bioinformatics
  • Data Management
  • Epigenetics
  • Metagenomics
  • NGS
  • High-Throughput Screening
  • Personalized / Targeted Therapeutics
  • Diagnostic & Clinical Applications
  • Venture Capitalists
  • Licensing or Technology Transfer
  • Business Development/In-Licensing
  • Regulatory
  • Market Access
  • Clinical trials
Media partners